Cleared Traditional

K203738 - Qitexio (FDA 510(k) Clearance)

Mar 2022
Decision
447d
Days
Class 2
Risk

K203738 is an FDA 510(k) clearance for the Qitexio. This device is classified as a Syringe, Piston (Class II - Special Controls, product code FMF).

Submitted by Medex (Saint-Priest, FR). The FDA issued a Cleared decision on March 14, 2022, 447 days after receiving the submission on December 22, 2020.

This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 880.5860.

Submission Details

510(k) Number K203738 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 22, 2020
Decision Date March 14, 2022
Days to Decision 447 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF

Device Classification

Product Code FMF - Syringe, Piston
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5860

Similar Devices - FMF Syringe, Piston

All 23
Profoject™ Insulin Syringes
K253068 · CMT Health PTE., Ltd. · Feb 2026
Instylla Delivery Kit
K253769 · Instylla, Inc. · Dec 2025
DuoprossTM Smart Cap (Type I)
K252518 · Duopross Meditech Corporate · Dec 2025
Verisafe Safety Retractable Insulin Syringes
K250192 · Promisemed Hangzhou Meditech Co., Ltd. · Dec 2025
Merit Syringe
K250853 · Merit Medical Systems, Inc. · Nov 2025
Monoject™ 1mL Tuberculin Syringe Luer-Lock Tip (1180100777)
K243660 · Cardinalhealth · Aug 2025